欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Meloxicam combined with sorafenib synergistically inhibits tumor growth of human hepatocellular carc
ISSN号:1021-335X
期刊名称:Oncology Reports
时间:2015.8
页码:2142-2150
相关项目:Clusterin通过线粒体凋亡通路调节肝细胞肝癌化疗耐受机理的研究
作者:
Zhong J|Xiu P|李杰|
同期刊论文项目
Clusterin通过线粒体凋亡通路调节肝细胞肝癌化疗耐受机理的研究
期刊论文 9
同项目期刊论文
Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplas
Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2-Dependent and -In
Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by act
T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy
Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma.
Integrin avb3 is required for cathepsin B-induced hepatocellular carcinoma progression.
Clusterin: Review of research progress and looking aheadto direction in hepatocellular carcinoma